Healthcare / News • 12 January 2026

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

OneVentures

Read the full article: Global News Wire

You may also like

16 October 2026

OneVentures

Investors flock to tax-free venture capital funds after budget change


Sarah Meibusch, OneVentures Partner & Head of Healthcare

07 September 2026

Healthcare

Big pharma eyes Australian biotech as $300b patent cliff looms


17 September 2026

Growth Credit

Building the right funding stack for growth.


Sarah Meibusch, OneVentures Partner & Head of Healthcare

17 April 2026

OneVentures

Meet the women steering Australia’s high-tech future

Read the full article: Australian Financial Review
afr.com/work-and-careers/leaders/meet-the-women-steering-australia-s-high-tech-future-20260210-p5o167

View All